The puzzling issue of silica toxicity: are silanols bridging the gaps between surface states and pathogenicity?


Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
16 08 2019
Historique:
received: 21 02 2019
accepted: 05 08 2019
entrez: 18 8 2019
pubmed: 20 8 2019
medline: 25 2 2020
Statut: epublish

Résumé

Silica continues to represent an intriguing topic of fundamental and applied research across various scientific fields, from geology to physics, chemistry, cell biology, and particle toxicology. The pathogenic activity of silica is variable, depending on the physico-chemical features of the particles. In the last 50 years, crystallinity and capacity to generate free radicals have been recognized as relevant features for silica toxicity. The 'surface' also plays an important role in silica toxicity, but this term has often been used in a very general way, without defining which properties of the surface are actually driving toxicity. How the chemical features (e.g., silanols and siloxanes) and configuration of the silica surface can trigger toxic responses remains incompletely understood. Recent developments in surface chemistry, cell biology and toxicology provide new avenues to improve our understanding of the molecular mechanisms of the adverse responses to silica particles. New physico-chemical methods can finely characterize and quantify silanols at the surface of silica particles. Advanced computational modelling and atomic force microscopy offer unique opportunities to explore the intimate interactions between silica surface and membrane models or cells. In recent years, interdisciplinary research, using these tools, has built increasing evidence that surface silanols are critical determinants of the interaction between silica particles and biomolecules, membranes, cell systems, or animal models. It also has become clear that silanol configuration, and eventually biological responses, can be affected by impurities within the crystal structure, or coatings covering the particle surface. The discovery of new molecular targets of crystalline as well as amorphous silica particles in the immune system and in epithelial lung cells represents new possible toxicity pathways. Cellular recognition systems that detect specific features of the surface of silica particles have been identified. Interdisciplinary research bridging surface chemistry to toxicology is progressively solving the puzzling issue of the variable toxicity of silica. Further interdisciplinary research is ongoing to elucidate the intimate mechanisms of silica pathogenicity, to possibly mitigate or reduce surface reactivity.

Sections du résumé

BACKGROUND
Silica continues to represent an intriguing topic of fundamental and applied research across various scientific fields, from geology to physics, chemistry, cell biology, and particle toxicology. The pathogenic activity of silica is variable, depending on the physico-chemical features of the particles. In the last 50 years, crystallinity and capacity to generate free radicals have been recognized as relevant features for silica toxicity. The 'surface' also plays an important role in silica toxicity, but this term has often been used in a very general way, without defining which properties of the surface are actually driving toxicity. How the chemical features (e.g., silanols and siloxanes) and configuration of the silica surface can trigger toxic responses remains incompletely understood.
MAIN BODY
Recent developments in surface chemistry, cell biology and toxicology provide new avenues to improve our understanding of the molecular mechanisms of the adverse responses to silica particles. New physico-chemical methods can finely characterize and quantify silanols at the surface of silica particles. Advanced computational modelling and atomic force microscopy offer unique opportunities to explore the intimate interactions between silica surface and membrane models or cells. In recent years, interdisciplinary research, using these tools, has built increasing evidence that surface silanols are critical determinants of the interaction between silica particles and biomolecules, membranes, cell systems, or animal models. It also has become clear that silanol configuration, and eventually biological responses, can be affected by impurities within the crystal structure, or coatings covering the particle surface. The discovery of new molecular targets of crystalline as well as amorphous silica particles in the immune system and in epithelial lung cells represents new possible toxicity pathways. Cellular recognition systems that detect specific features of the surface of silica particles have been identified.
CONCLUSIONS
Interdisciplinary research bridging surface chemistry to toxicology is progressively solving the puzzling issue of the variable toxicity of silica. Further interdisciplinary research is ongoing to elucidate the intimate mechanisms of silica pathogenicity, to possibly mitigate or reduce surface reactivity.

Identifiants

pubmed: 31419990
doi: 10.1186/s12989-019-0315-3
pii: 10.1186/s12989-019-0315-3
pmc: PMC6697921
doi:

Substances chimiques

Silanes 0
TRPV Cation Channels 0
silanol 079V3J9O3X
Silicon Dioxide 7631-86-9

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Références

Br J Ind Med. 1950 Jan;7(1):27-36
pubmed: 15403149
Ann Occup Hyg. 1998 Jul;42(5):287-94
pubmed: 9729916
G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):395-7
pubmed: 18409742
Immunol Rev. 2010 Jan;233(1):203-17
pubmed: 20193001
J Chem Theory Comput. 2012 Mar 13;8(3):1037-47
pubmed: 26593364
Part Fibre Toxicol. 2018 May 21;15(1):23
pubmed: 29783987
Science. 2008 May 2;320(5876):674-7
pubmed: 18403674
AMA Arch Ind Health. 1957 Sep;16(3):188-202
pubmed: 13457438
J Phys Chem Lett. 2018 May 3;9(9):2186-2189
pubmed: 29634900
Ann Occup Hyg. 1998 Nov;42(8):521-30
pubmed: 9838865
Am J Respir Cell Mol Biol. 2004 Sep;31(3):292-301
pubmed: 15191911
J Exp Med. 1971 Jan 1;133(1):100-12
pubmed: 4321912
J Toxicol Environ Health. 1985;16(3-4):415-24
pubmed: 3003373
IARC Monogr Eval Carcinog Risks Hum. 1997;68:1-475
pubmed: 9303953
Nat Immunol. 2008 Aug;9(8):847-56
pubmed: 18604214
Exp Lung Res. 1987;13(2):205-22
pubmed: 2822380
Biochim Biophys Acta. 2016 Sep;1858(9):2163-2170
pubmed: 27349734
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9035-40
pubmed: 18577586
Chem Res Toxicol. 2002 Sep;15(9):1166-73
pubmed: 12230410
Part Fibre Toxicol. 2016 Sep 20;13(1):51
pubmed: 27650313
Part Fibre Toxicol. 2014 Nov 19;11:58
pubmed: 25406505
Part Fibre Toxicol. 2014 Dec 13;11:69
pubmed: 25497724
J Am Chem Soc. 2012 Sep 26;134(38):15790-804
pubmed: 22924492
J Occup Med Toxicol. 2015 Jul 10;10:23
pubmed: 26199640
Arch Toxicol. 2017 Sep;91(9):2967-3010
pubmed: 28573455
Lancet. 2012 May 26;379(9830):2008-18
pubmed: 22534002
Inhal Toxicol. 2007;19 Suppl 1:39-48
pubmed: 17886049
Toxicol Appl Pharmacol. 1996 Nov;141(1):84-92
pubmed: 8917679
Carcinogenesis. 2002 Jul;23(7):1111-20
pubmed: 12117767
J Toxicol Environ Health. 1991 Jul;33(3):303-15
pubmed: 1649918
Part Fibre Toxicol. 2010 May 21;7:13
pubmed: 20492675
J Lipid Res. 2019 Apr;60(4):721-727
pubmed: 30782961
Part Fibre Toxicol. 2012 Nov 19;9:44
pubmed: 23164071
Int J Hyg Environ Health. 2004 Jul;207(3):203-16
pubmed: 15330388
Part Fibre Toxicol. 2017 Nov 3;14(1):43
pubmed: 29100528
Toxicol Appl Pharmacol. 2001 Oct 1;176(1):10-7
pubmed: 11578144
Part Fibre Toxicol. 2016 Aug 12;13(1):40
pubmed: 27519871
Front Immunol. 2016 Mar 11;7:97
pubmed: 27014276
Environ Res. 2017 Nov;159:164-175
pubmed: 28802207
Am Rev Respir Dis. 1990 Jan;141(1):111-6
pubmed: 2153350
Part Fibre Toxicol. 2016 Jun 10;13(1):32
pubmed: 27286702
Cell Rep. 2017 Jan 31;18(5):1298-1311
pubmed: 28147282
Part Fibre Toxicol. 2014 Dec 19;11:76
pubmed: 25522817
Ann Work Expo Health. 2017 May 1;61(4):468-480
pubmed: 28355417
J Phys Chem Lett. 2016 Aug 18;7(16):3229-34
pubmed: 27483195
Inhal Toxicol. 2015;27(8):363-77
pubmed: 26194035
Inhaled Part. 1970;1:415-21
pubmed: 4358974
Respir Res. 2009 Mar 19;10:25
pubmed: 19298665
J Colloid Interface Sci. 2017 Dec 1;507:95-106
pubmed: 28780339
Annu Rev Phys Chem. 2016 May 27;67:159-84
pubmed: 26980304
Front Immunol. 2018 Jan 22;8:2000
pubmed: 29403480
Adv Healthc Mater. 2017 Nov;6(21):
pubmed: 28752592
Chem Res Toxicol. 2017 Jan 17;30(1):469-485
pubmed: 27992190
Chem Res Toxicol. 2013 Aug 19;26(8):1188-98
pubmed: 23819533

Auteurs

Cristina Pavan (C)

UCLouvain, Louvain centre for Toxicology and Applied Pharmacology (LTAP), Brussels, Belgium.

Massimo Delle Piane (M)

Bremen Center for Computational Material Science (BCCMS), Center for Environmental Research and Sustainable Technology (UFT), University of Bremen, Bremen, Germany.

Maria Gullo (M)

INAIL Piemonte, Turin, Italy.

Francesca Filippi (F)

INAIL Piemonte, Turin, Italy.

Bice Fubini (B)

G. Scansetti Center, University of Torino, Turin, Italy.

Peter Hoet (P)

Department of Public Health and Primary Care, KU Leuven, Laboratory of Toxicology, Unit of Environment and Health, Leuven, Belgium.

Claire J Horwell (CJ)

Institute of Hazard, Risk and Resilience, Department of Earth Sciences, Durham University, Durham, UK.

François Huaux (F)

UCLouvain, Louvain centre for Toxicology and Applied Pharmacology (LTAP), Brussels, Belgium.

Dominique Lison (D)

UCLouvain, Louvain centre for Toxicology and Applied Pharmacology (LTAP), Brussels, Belgium. dominique.lison@uclouvain.be.

Cristina Lo Giudice (C)

UCLouvain, Institute of Biomolecular Science and Technology, NanoBioPhysics, Louvain-la-Neuve, Belgium.

Gianmario Martra (G)

Department of Chemistry and Nanostructured Interfaces and Surfaces -NIS Centre, University of Torino, Turin, Italy.

Eliseo Montfort (E)

Instituto de Tecnología Cerámica, Universitat Jaume I, Castellón, Spain.

Roel Schins (R)

IUF Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.

Marialore Sulpizi (M)

Institute of Physics, University of Mainz, Mainz, Germany.

Karsten Wegner (K)

ETH Zürich, Zürich, Switzerland.

Michelle Wyart-Remy (M)

EUROSIL, European Association of industrial silica producers, Brussels, Belgium.

Christina Ziemann (C)

Fraunhofer Institute for Toxicology and Experimental Medicine, ITEM, Hannover, Germany.

Francesco Turci (F)

Department of Chemistry, G. Scansetti Center, University of Torino, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH